Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection
- 29 November 1999
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 735 (2) , 159-170
- https://doi.org/10.1016/s0378-4347(99)00419-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Lack of pharmacokinetic interaction between nelfinavir and nevirapineAIDS, 1998
- A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)‐1 Protease, to Treat HIV InfectionThe Journal of Infectious Diseases, 1998
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- NelfinavirDrugs, 1998
- Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 ProteaseJournal of Medicinal Chemistry, 1997
- High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- A strategy for validation of bioanalytical methodsJournal of Pharmaceutical and Biomedical Analysis, 1996
- Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1992
- Validation of Bioanalytical MethodsPharmaceutical Research, 1991